Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Veronica Hernström

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Parkinson'S Disease|August 4, 2025
Personality Trait Changes After Device-Aided Therapy: Insights From Parkinson's Patients and Their Close RelativesMonica Scharfenort, Veronica Hernström, Kristina Rosqvist, et al.
The Lancet. Digital Health|February 4, 2025
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy studyVeronica Hernström, Viktoria Josefsson, Hanna Sartor, et al.
Lancet (London, England)|June 25, 2026
AI-supported mammography screening: measuring benefit - Authors' replyJessie Gommers, Veronica Hernström, Viktoria Josefsson, et al.
Lancet (London, England)|January 31, 2026
Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trialJessie Gommers, Veronica Hernström, Viktoria Josefsson, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Parkinson'S Disease|August 4, 2025
Personality Trait Changes After Device-Aided Therapy: Insights From Parkinson's Patients and Their Close RelativesMonica Scharfenort, Veronica Hernström, Kristina Rosqvist, et al.
The Lancet. Digital Health|February 4, 2025
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI): a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy studyVeronica Hernström, Viktoria Josefsson, Hanna Sartor, et al.
Lancet (London, England)|June 25, 2026
AI-supported mammography screening: measuring benefit - Authors' replyJessie Gommers, Veronica Hernström, Viktoria Josefsson, et al.
Lancet (London, England)|January 31, 2026
Interval cancer, sensitivity, and specificity comparing AI-supported mammography screening with standard double reading without AI in the MASAI study: a randomised, controlled, non-inferiority, single-blinded, population-based, screening-accuracy trialJessie Gommers, Veronica Hernström, Viktoria Josefsson, et al.
Pageof 1